Digestive system in psoriasis: an update.

Authors:
Daniel Pietrzak
Daniel Pietrzak
Medical University of Lublin
Aldona Pietrzak
Aldona Pietrzak
Medical University of Lublin
Poland
Dorota Krasowska
Dorota Krasowska
Medical University of Lublin
Poland
Andrzej Borzęcki
Andrzej Borzęcki
Medical University of Lublin
Maja Baranowska
Maja Baranowska
Institute of Fine Arts
Kristian Reich
Kristian Reich
Georg-August-University
Germany

Arch Dermatol Res 2017 Nov 13;309(9):679-693. Epub 2017 Sep 13.

Dermatologikum Hamburg, Hamburg, Germany.

Psoriasis is a chronic inflammatory immune-mediated disorder associated and often coexisting with many other immune-related clinical conditions including those affecting the gastrointestinal tract. Data obtained from the reviewed literature suggest an association between psoriasis and pathologies of the oral cavity, both psoriasis-specific lesions, as well as non-specific, such as geographic tongue or fissured tongue. These findings show the importance of thorough examination of oral mucosa in psoriatic patients. Inflammatory bowel diseases (IBD) are also linked with psoriasis. Crohn's disease and ulcerative colitis share a common genetic background, inflammatory pathways and have an evident iatrogenic anti-TNF treatment link, necessitating dermatological or gastroenterological care in patients with IBD or psoriasis, respectively, as well as treatment adjusted to manifestations. The presence of celiac disease-specific antibodies in psoriatic patients and their correlation with the severity of the disease show the association between these disorders. The linking pathogenesis comprises vitamin D deficiency, immune pathway, genetic background and increase in the intestinal permeability, which suggests a potential benefit from gluten-free diet among psoriatic patients. The link between psoriasis and non-alcoholic fatty liver disease implies screening patients for components of metabolic syndrome and lifestyle changes necessity. Some studies indicate increased prevalence of cancer in patients with psoriasis, probably due to negative influence of skin lesion impact on lifestyle rather than the role of psoriasis in carcinogenesis. However, there are no sufficient data to exclude such an oncogenic hit, which is yet to be confirmed. Therefore, all psoriasis-associated comorbidities establish the importance of a multidisciplinary approach in the treatment of these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00403-017-1775-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648743PMC
November 2017
13 Reads

Publication Analysis

Top Keywords

psoriatic patients
12
psoriasis
8
genetic background
8
patients
7
association disorders
4
disorders linking
4
linking pathogenesis
4
pathogenesis comprises
4
disease association
4
severity disease
4
antibodies psoriatic
4
patients correlation
4
correlation severity
4
comprises vitamin
4
vitamin deficiency
4
intestinal permeability
4
permeability suggests
4
suggests potential
4
potential benefit
4
increase intestinal
4

Similar Publications

Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.

J Am Acad Dermatol 2018 02;78(2):383-394

Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia. Electronic address:

Background: There is a significant association between psoriasis and inflammatory bowel disease (IBD). Many treatments for psoriasis and psoriatic arthritis are also used for IBD.

Objective: To assess therapeutic options for patients with psoriasis and concurrent IBD. Read More

View Article
February 2018

Psoriasis, the liver, and the gastrointestinal tract.

Dermatol Ther 2010 Mar-Apr;23(2):155-9

Department of Medicine, University of Verona, Verona, Italy.

Psoriasis is a common chronic inflammatory, immune-mediated skin disease that is frequently associated with comorbidities including psoriatic arthropathy, chronic inflammatory bowel diseases, and cardio-metabolic disorders. In particular, nonalcoholic fatty liver disease affects about half of patients, Crohn's disease 0.5% and celiac disease 0. Read More

View Article
July 2010

[Psoriasis and inflammatory bowel diseases].

Authors:
E Delaporte

Ann Dermatol Venereol 2012 Apr;139 Suppl 2:S46-52

Université de Lille 2 et Service de Dermatologie, Hôpital Claude-Huriez, CHRU, Rue Michel Polonovski 59037 Lille cedex, France.

Psoriasis and inflammatory bowel diseases (Crohn's disease and ulcerative colitis) are among the immune-mediated inflammatory diseases. This group includes approximately 80 disorders, some of which can at times be associated in a single patient. In psoriasis, Crohn's disease may be observed slightly more frequently, but ulcerative colitis and celiac disease are also an issue. Read More

View Article
April 2012

Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study.

J Crohns Colitis 2015 Sep 23;9(9):699-707. Epub 2015 Apr 23.

GI Unit, Department of Systems Medicine, University Tor Vergata of Rome, Italy

Background And Aims: Whether inflammatory bowel disease [IBD] is associated with specific psoriasis phenotypes is undefined. In a case-control prospective study, we aimed to assess the severity and phenotype of psoriasis in IBD vs matched non-IBD controls with psoriasis [non-IBD].

Methods: From 2011 to 2013, dermatological assessment was performed in all IBD patients showing lesions requiring characterisation. Read More

View Article
September 2015